Wartenberg et al. [34] studied the regulation of multidrug resistance by HIF-1 and reactive oxygen species, and Li et al. [35] confirmed the role of the bioreactor in mimicking tumor microenvironments in personalized medicine. This evidence concerns the gene HIF1A and neoplasm.